Autoimmune Hemolytic Anemia
📧 Sign up to get email alerts when something new happens for Autoimmune Hemolytic Anemia.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-08-01EMA Authorised: Enjaymo (sutimlimab) — Recordati Rare Diseases
EMA authorised Enjaymo (sutimlimab) for the treatment of cold agglutinin disease (autoimmune hemolytic anemia), with orphan medicine designa…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: National Longitudinal Cohort of Hematological Diseases- Autoimmune Hemolytic Anemia
Clinical trial update describes a National Longitudinal Cohort of Hematological Diseases study in China focusing on autoimmune hemolytic ane…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases [Phase 1]
Phase 1 clinical trial update for UCAR T-cell therapy targeting CD19/BCMA in relapse/refractory autoimmune diseases. The study includes seve…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: CNCT19 for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy. [Phase 1]
This Phase 1 clinical trial update reports evaluation of CNCT19, an autologous CD19 CAR-T cell therapy, for autoimmune hemolytic anemia in p…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Autoimmune Hemolytic Anemia [EARLY_Phase 1]
An early-phase (Phase 1) UCAR T-cell therapy targeting CD19 and BCMA is being investigated for relapsed or refractory Autoimmune Hemolytic A…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: The Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune Antibody Mediated Hemolytic Anemia [Phase 1]
Phase 1 safety data on repurposing daratumumab for relapsed or refractory autoimmune antibody-mediated hemolytic anemia; the study has compl…
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia
This study update describes the establishment of a biological bank and current recruitment for patients with autoimmune cytopenias at a refe…
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: Second-line Treatment of Primary Autoimmune Hemolytic Anemia [Phase 3]
Phase 3 clinical trial update for second-line treatment of primary autoimmune hemolytic anemia; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: A Multicenter Prospective Study of Iptacopan in the Treatment of Refractory/Relapsed Autoimmune Hemolytic Anemia (AIHA) [NA]
A multicenter prospective trial evaluating iptacopan for refractory/relapsed autoimmune hemolytic anemia (warm and cold types) is planned bu…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: A Study of YTS109 Cell Injection in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia [Phase 1]
Phase 1 study evaluating YTS109 cell injections, an anti-CD19 STAR T-cell therapy, in patients with relapsed/refractory autoimmune hemolytic…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy. [Phase 1]
A Phase 1 clinical trial is evaluating CD19/BCMA CAR T-cells, including universal allogeneic CAR T-cells, in autoimmune hemolytic anemia pat…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia
This clinical trial update describes a prospective evaluation of diagnosis and treatment among patients with autoimmune cytopenias, includin…
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia [Phase 2]
Phase 2 trial assessing the safety and efficacy of ibrutinib in patients with refractory or relapsed autoimmune hemolytic anemia.
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: IASO-782 in Autoimmune Hematological Diseases [Phase 1]
Phase 1 clinical trial update for IASO-782 in autoimmune hematological diseases, including immune thrombocytopenia and autoimmune hemolytic …
-
CLINICAL_TRIALS trial_result · 2024-07-15Clinical Trial Update: Role of T Follicular Helper Cells in Autoimmune Hemolytic Anemia (TFH in AIHA)
A clinical trial evaluating the role of T Follicular Helper Cells in Autoimmune Hemolytic Anemia has completed, providing results on TFH inv…
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Acalabrutinib for the Treatment of Relapsed or Refractory Autoimmune Hemolytic Anemia in Patients With Chronic Lymphocytic Leukemia [Phase 2]
A phase 2 trial evaluating acalabrutinib for relapsed or refractory autoimmune hemolytic anemia in patients with chronic lymphocytic leukemi…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic Anemia [Phase 2]
Phase 2 clinical trial evaluating a single-dose anti-CD20 antibody in combination with bortezomib for relapsed or refractory autoimmune hemo…
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: The Safety and Efficacy of Zanubrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia [Phase 2]
A Phase 2 clinical trial evaluating the safety and efficacy of zanubrutinib in refractory/relapsed autoimmune hemolytic anemia is ongoing, w…
-
CLINICAL_TRIALS trial_result · 2022-09-22Clinical Trial Update: A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia [Phase 2]
This clinical trial update reports Phase 2 results for INCB050465 in participants with autoimmune hemolytic anemia. Results were posted on 2…
-
CLINICAL_TRIALS trial_result · 2021-10-27Clinical Trial Update: Reappraisal of the Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus Erythematosus [Phase 3]
Phase 3 clinical trial reappraising therapies for refractory autoimmune hemolytic anemia in systemic lupus erythematosus is in progress, wit…
-
CLINICAL_TRIALS trial_result · 2020-01-10Clinical Trial Update: Ibrutinib in Steroid Refractory Autoimmune Hemolytic Anemia [Phase 2]
Phase 2 clinical trial update for ibrutinib in steroid-refractory autoimmune hemolytic anemia.
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Tacrolimus Treatment for Refractory Autoimmune Cytopenia [Phase 4]
A Phase 4 clinical trial update evaluating tacrolimus for refractory autoimmune cytopenia, including autoimmune hemolytic anemia and pure re…
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating interleukin-2 in patients with active warm autoimmune hemolytic anemia resistant to conventional treatme…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Treatment of Autoimmune Thrombocytopenia (AITP) [Phase 1]
A Phase 1 clinical trial evaluating treatment for autoimmune thrombocytopenia has completed enrollment. The study also relates to autoimmune…
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease [Phase 2]
Phase 2 trial update for bendamustine plus rituximab in Cold Agglutinin Disease; the study has completed.